Steward Partners Investment Advisory LLC Has $1.47 Million Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Steward Partners Investment Advisory LLC decreased its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 64.3% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,313 shares of the company's stock after selling 27,617 shares during the period. Steward Partners Investment Advisory LLC's holdings in HealthEquity were worth $1,469,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Arcadia Investment Management Corp MI acquired a new position in shares of HealthEquity during the fourth quarter valued at $26,000. Smartleaf Asset Management LLC raised its holdings in HealthEquity by 34.3% during the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after purchasing an additional 98 shares during the last quarter. Proficio Capital Partners LLC acquired a new position in HealthEquity during the 4th quarter valued at about $39,000. UMB Bank n.a. boosted its stake in shares of HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company's stock valued at $40,000 after purchasing an additional 164 shares during the last quarter. Finally, First Horizon Advisors Inc. grew its position in shares of HealthEquity by 50.7% during the 4th quarter. First Horizon Advisors Inc. now owns 1,115 shares of the company's stock worth $107,000 after buying an additional 375 shares during the period. Institutional investors and hedge funds own 99.55% of the company's stock.

HealthEquity Stock Down 2.0 %

Shares of NASDAQ:HQY traded down $1.90 during mid-day trading on Thursday, reaching $93.88. 568,001 shares of the stock were exchanged, compared to its average volume of 654,199. The company has a market cap of $8.14 billion, a P/E ratio of 86.13, a P/E/G ratio of 1.60 and a beta of 0.62. The stock's 50 day simple moving average is $105.74 and its 200-day simple moving average is $94.94. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a one year low of $65.01 and a one year high of $115.59.

Remove Ads

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter last year, the company earned $0.40 earnings per share. As a group, equities research analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the business's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now owns 78,219 shares of the company's stock, valued at $8,704,992.51. The trade was a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 2.20% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the stock. Barrington Research increased their price objective on shares of HealthEquity from $105.00 to $120.00 and gave the company an "outperform" rating in a report on Monday, December 2nd. Mizuho assumed coverage on HealthEquity in a research note on Wednesday, December 4th. They issued an "outperform" rating and a $126.00 price target on the stock. JMP Securities lifted their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Tuesday, December 10th. Bank of America upped their price objective on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. Finally, BTIG Research raised their target price on HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a report on Thursday, November 14th. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. Based on data from MarketBeat.com, HealthEquity has an average rating of "Moderate Buy" and an average target price of $113.54.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.